New type of HIV vaccine moves to phase II testing in humans
A new HIV vaccine will be tested on 600 people in North America in 2017. The type of vaccine, known as inactivated vaccine, uses a dead version of the virus to trigger antibodies. There have been similar success with this type of vaccine against flu, polio and hepatitis ...